Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Borer

Showing results (21-30 of 394) with videos related to

Pageof 40
Sort By:
European Heart Journal|September 18, 2013
Drug-induced valve disease and considerations of benefit versus riskJeffrey S Borer
Circulation. Heart Failure|July 18, 2013
Mitral regurgitation: has another magic bullet bitten the dust?Jeffrey S Borer
JACC. Cardiovascular Interventions|January 8, 2021
Iatrogenic Atrial Septal Defect After Mitral Valve Repair for Mitral Regurgitation: To Close or Not to Close, That Is the QuestionJeffrey S Borer
JACC. Heart Failure|February 5, 2015
How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?Jeffrey S Borer
The New England Journal of Medicine|December 24, 1987
t-PA and the principles of drug approvalJ S Borer
Cardiology|January 1, 1984
Current status of noninvasive testing: an overviewJ S Borer
Journal of the American College of Cardiology|April 4, 2014
Early surgery or watchful waiting for asymptomatic severe degenerative mitral regurgitation: is the answer now clear?Jeffrey S Borer
Journal of Cardiovascular Pharmacology|June 21, 2006
Cyclooxygenase inhibition: what should we do to resolve the confusion? An American perspectiveJeffrey S Borer
Advances in Cardiology|August 29, 2006
Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradineJeffrey S Borer
Pharmacological Research|April 20, 2006
Therapeutic effects of I(f) blockade: evidence and perspectiveJeffrey S Borer
Pageof 40

Showing results (21-30 of 394) with videos related to

Sort By:
Pageof 40
European Heart Journal|September 18, 2013
Drug-induced valve disease and considerations of benefit versus riskJeffrey S Borer
Circulation. Heart Failure|July 18, 2013
Mitral regurgitation: has another magic bullet bitten the dust?Jeffrey S Borer
JACC. Cardiovascular Interventions|January 8, 2021
Iatrogenic Atrial Septal Defect After Mitral Valve Repair for Mitral Regurgitation: To Close or Not to Close, That Is the QuestionJeffrey S Borer
JACC. Heart Failure|February 5, 2015
How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?Jeffrey S Borer
The New England Journal of Medicine|December 24, 1987
t-PA and the principles of drug approvalJ S Borer
Cardiology|January 1, 1984
Current status of noninvasive testing: an overviewJ S Borer
Journal of the American College of Cardiology|April 4, 2014
Early surgery or watchful waiting for asymptomatic severe degenerative mitral regurgitation: is the answer now clear?Jeffrey S Borer
Journal of Cardiovascular Pharmacology|June 21, 2006
Cyclooxygenase inhibition: what should we do to resolve the confusion? An American perspectiveJeffrey S Borer
Advances in Cardiology|August 29, 2006
Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradineJeffrey S Borer
Pharmacological Research|April 20, 2006
Therapeutic effects of I(f) blockade: evidence and perspectiveJeffrey S Borer
Pageof 40